Sukhmani K. Padda

5.1k citations
94 papers · 1.5k indexed · h-index 21

Sukhmani K. Padda

85 papers receiving 1.4k citations

Peers

Sukhmani K. Padda
Comparison fields: 5 of 84
  • Oncology 724
  • Neurology 317
  • Pulmonary and Respiratory Medicine 640
  • Cancer Research 181
  • Endocrinology, Diabetes and Metabolism 126
Replace Fumihiko Hirai with:
Fumihiko Hirai Japan
Teresa Alonso‐Gordoa Spain
Akira Ono Japan
Satoshi Igawa Japan
Rutika Mehta United States
Ana Custodio Spain
Fei Yuan China
Daisuke Ban Japan
Takehito Shukuya Japan
Maria Pia Brizzi Italy
Sukhmani K. Padda relative to Fumihiko Hirai Japan Fumihiko Hirai's profile →
Citations per field
00.5×1.5×1.8×
Fumihiko Hirai · 1×
Citations per year

Countries citing papers authored by Sukhmani K. Padda

Since Specialization
Citations

This map shows the geographic impact of Sukhmani K. Padda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sukhmani K. Padda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sukhmani K. Padda more than expected).

Fields of papers citing papers by Sukhmani K. Padda

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sukhmani K. Padda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sukhmani K. Padda. The network helps show where Sukhmani K. Padda may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Sukhmani K. Padda, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Sukhmani K. Padda Line = papers co-authored together Sukhmani K. Padda links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20250
2 20241
3 20241
4 20234
5 20232
6 20225
7 202117
8 202114
9 20217
10 20211
11 202012
12 202039
13 20205
14 201980
15 201911
16 20195
17 20191
18 20181
19 201671
20 20151

About Sukhmani K. Padda

Sukhmani K. Padda is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Neurology, having authored 94 papers that have together received 1.5k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (51 papers), Lung Cancer Research Studies (28 papers), Myasthenia Gravis and Thymoma (17 papers), Cancer Genomics and Diagnostics (15 papers), Colorectal Cancer Treatments and Studies (15 papers), Lung Cancer Diagnosis and Treatment (12 papers), Neuroendocrine Tumor Research Advances (10 papers) and Cancer Immunotherapy and Biomarkers (9 papers). The work is most often cited by research in Oncology (724 citations), Neurology (317 citations) and Pulmonary and Respiratory Medicine (640 citations). Sukhmani K. Padda has collaborated with scholars based in United States, India and Canada. Frequent co-authors include Heather A. Wakelee, Joel W. Neal, Millie Das, Jessica A. Hellyer, Jonathan W. Riess, Jacqueline V. Aredo, Kavitha Ramchandran, Maximilian Diehn, Joseph B. Shrager and Bryan M. Burt. Their work appears in journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Clinical Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026